UFP Technologies, Inc. (NASDAQ:UFPT) is De Lisle Partners LLP’s 3rd Largest Position

De Lisle Partners LLP grew its stake in shares of UFP Technologies, Inc. (NASDAQ:UFPTFree Report) by 30.6% in the third quarter, Holdings Channel reports. The fund owned 66,573 shares of the industrial products company’s stock after acquiring an additional 15,603 shares during the quarter. UFP Technologies accounts for about 3.4% of De Lisle Partners LLP’s portfolio, making the stock its 3rd largest position. De Lisle Partners LLP’s holdings in UFP Technologies were worth $21,070,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently modified their holdings of UFPT. Congress Asset Management Co. increased its position in UFP Technologies by 0.4% in the third quarter. Congress Asset Management Co. now owns 246,303 shares of the industrial products company’s stock worth $78,004,000 after buying an additional 986 shares during the last quarter. Massachusetts Financial Services Co. MA grew its stake in shares of UFP Technologies by 2.6% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 105,118 shares of the industrial products company’s stock worth $27,737,000 after acquiring an additional 2,699 shares during the period. Swedbank AB purchased a new stake in UFP Technologies in the 1st quarter worth about $25,220,000. Mountain Pacific Investment Advisers LLC raised its stake in UFP Technologies by 0.3% in the 3rd quarter. Mountain Pacific Investment Advisers LLC now owns 92,976 shares of the industrial products company’s stock valued at $29,445,000 after acquiring an additional 238 shares during the period. Finally, Geneva Capital Management LLC lifted its holdings in UFP Technologies by 0.3% during the third quarter. Geneva Capital Management LLC now owns 80,362 shares of the industrial products company’s stock valued at $25,450,000 after purchasing an additional 243 shares during the last quarter. Institutional investors own 87.28% of the company’s stock.

Insider Activity at UFP Technologies

In other UFP Technologies news, VP Jason Holt sold 146 shares of the firm’s stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $342.69, for a total value of $50,032.74. Following the completion of the transaction, the vice president now owns 6,721 shares in the company, valued at $2,303,219.49. This trade represents a 2.13 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Cynthia L. Feldmann sold 647 shares of the company’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $352.30, for a total value of $227,938.10. Following the sale, the director now owns 4,049 shares in the company, valued at approximately $1,426,462.70. This represents a 13.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 13,326 shares of company stock worth $4,620,154. Corporate insiders own 6.17% of the company’s stock.

UFP Technologies Price Performance

UFPT opened at $321.92 on Thursday. The company has a market capitalization of $2.47 billion, a price-to-earnings ratio of 45.92 and a beta of 0.96. The company has a quick ratio of 1.43, a current ratio of 2.57 and a debt-to-equity ratio of 0.64. The firm has a 50-day moving average price of $307.63 and a 200-day moving average price of $298.77. UFP Technologies, Inc. has a twelve month low of $152.43 and a twelve month high of $366.41.

About UFP Technologies

(Free Report)

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.

Read More

Want to see what other hedge funds are holding UFPT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UFP Technologies, Inc. (NASDAQ:UFPTFree Report).

Institutional Ownership by Quarter for UFP Technologies (NASDAQ:UFPT)

Receive News & Ratings for UFP Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UFP Technologies and related companies with MarketBeat.com's FREE daily email newsletter.